Phase II study of short-course radiotherapy plus concomitant and adjuvant temozolomide in elderly patients with glioblastoma.
about
Treatment options and outcomes for glioblastoma in the elderly patientA review of management strategies of malignant gliomas in the elderly population.A Surveillance, Epidemiology and End Results-Medicare data analysis of elderly patients with glioblastoma multiforme: Treatment patterns, outcomes and costEfficacy and safety of second-line fotemustine in elderly patients with recurrent glioblastomaFeasibility evaluation of hypofractionated radiotherapy with concurrent temozolomide in elderly patients with glioblastoma.Hypofractionated short-course radiotherapy in elderly patients with glioblastoma multiforme: an analysis of the National Cancer DatabaseRadiation therapy for older patients with brain tumorsAssessment and treatment relevance in elderly glioblastoma patients.Elderly patients affected by glioblastoma treated with radiotherapy: the role of serum hemoglobin level.Management of elderly patients with gliomasShort-course radiotherapy in elderly patients with glioblastoma: feasibility and efficacy of results from a single centre.Radiotherapy plus concurrent or sequential temozolomide for glioblastoma in the elderly: a meta-analysis.Elderly patients with glioblastoma multiforme treated with concurrent temozolomide and standard- versus abbreviated-course radiotherapy.Comparison of radiation regimens in the treatment of Glioblastoma multiforme: results from a single institution.Factors associated with increased survival after surgical resection of glioblastoma in octogenarians.Durable response of glioblastoma to adjuvant therapy consisting of temozolomide and a weekly dose of AMD3100 (plerixafor), a CXCR4 inhibitor, together with lapatinib, metformin and niacinamideEnzastaurin before and concomitant with radiation therapy, followed by enzastaurin maintenance therapy, in patients with newly diagnosed glioblastoma without MGMT promoter hypermethylation.Outcomes in newly diagnosed elderly glioblastoma patients after concomitant temozolomide administration and hypofractionated radiotherapy.High-grade glioma in elderly patients: can the oncogeriatrician help?Current status and perspectives of interventional clinical trials for glioblastoma - analysis of ClinicalTrials.govGlioblastoma: approach to treat elderly patients.Elderly patients with glioblastoma: the treatment challenge.MGMT testing--the challenges for biomarker-based glioma treatment.Current evidence of temozolomide and bevacizumab in treatment of gliomas.Treating glioblastoma in the elderly.Radiation therapy for older adults with glioblastoma: radical treatment, palliative treatment, or no treatment at all?Modulations in the Peripheral Immune System of Glioblastoma Patient Is Connected to Therapy and Tumor Progression-A Case Report from the IMMO-GLIO-01 Trial.Recent advances in targeted therapy for glioblastoma.Glioblastoma multiforme (GBM) in the elderly: initial treatment strategy and overall survival.Management of GBM: a problem of local recurrence.Oncological patterns of care and outcomes for 265 elderly patients with newly diagnosed glioblastoma in France.The predictive but not prognostic value of MGMT promoter methylation status in elderly glioblastoma patients: a meta-analysis.High-grade glioma: elderly patients, older treatments.Metronomic chemotherapy with daily low-dose temozolomide and celecoxib in elderly patients with newly diagnosed glioblastoma multiforme: a retrospective analysis.Predictors of survival and effect of short (40 Gy) or standard-course (60 Gy) irradiation plus concomitant temozolomide in elderly patients with glioblastoma: a multicenter retrospective study of AINO (Italian Association of Neuro-Oncology).Association of dynamic susceptibility contrast enhanced MR Perfusion parameters with prognosis in elderly patients with glioblastomas.Combined-modality hypofractionated radiotherapy for elderly patients with glioblastoma: setting a new standard.Abbreviated course of radiation therapy with concurrent temozolomide for high-grade glioma in patients of advanced age or poor functional status.Comorbidity assessment and adjuvant radiochemotherapy in elderly affected by glioblastoma.The radiosurgery fractionation quandary: single fraction or hypofractionation?
P2860
Q26991605-C13CE66F-416D-4EF6-A9C0-3BF24C72F1FFQ27692579-FF2DA9C8-CE57-445F-A1AC-7277D7783A44Q31029542-011898A5-EF7B-4591-83A4-5B05B87C5736Q33406919-49CE54B6-51DB-4CB4-8A6B-11BDA73441B8Q33433682-B81A94A2-2D08-4E4D-988B-532091E08F4BQ33775341-B740AA04-AD08-4057-93BC-587583982272Q33815025-3D7C88A4-7F5B-455B-ADE1-CA3B912A9F3AQ34359650-79265197-9468-4737-9A03-626D04984A84Q34461414-3D318169-C9F8-47F5-AFC3-78321565A154Q34641001-FA951564-5825-4C55-94FE-95172FEC6D66Q34691877-52B0DD80-AA0B-4D5C-8155-3B054A1F26F9Q35004927-F44A48CC-C884-4D50-8FAD-1169820A2CFBQ35043237-CA65AD9E-544F-4677-BAF2-DD160F9BD0C5Q35575434-327F2611-070A-4FF1-B5A6-9FA3E267BA79Q35610849-46D804D5-2323-422A-8FAA-C8BDD2D7CEFBQ37136281-396654EF-C3A4-44AC-A1F3-3942304E215FQ37187715-F7DFDC96-31EB-4B04-9640-0E77A2ED0B51Q37226536-D6BE1EE4-5BAF-4F11-BCF8-93E3E3FD7619Q37388217-C8DBC1B2-999F-4FB8-99B9-E0541AD8F080Q37555973-77639C50-B682-4E72-A892-EB12D7EAF8D0Q38079529-B3FE1AE9-0E9B-4679-B0C9-8F20CEF5FEA5Q38151772-830CB1F7-B285-4A96-83AC-51681C9B1A9BQ38218848-09AC11B1-14D7-42E4-9333-1608D700CADAQ38230650-9A6C9847-FE06-454C-8704-1679785B2111Q38233427-964732E7-EE50-47D7-93FB-C3AF4F60E2B3Q38237311-74CA4189-3C6D-4948-B8FE-28BE51073D35Q38374300-573AD98D-FE9C-490A-9900-285262D6DEFCQ38539386-1F7EC2BF-D427-48D6-BC10-A699625B31B3Q38773618-AFB12A68-0D47-45DA-91E0-ADF656B10EFAQ39220867-7A916097-85B3-409B-8EC7-A7897A60C40AQ39250933-0F981C8A-8531-4FFD-B3BE-82480B1666F8Q39266259-5F17939E-361D-4E72-A3A8-2FB72F5A4FDBQ39504320-418E1DC1-D541-428D-A5E9-3E4D5DECFA70Q40867629-B4EC28F2-D653-48D4-8611-1C812A21524AQ41282384-EFF0A2A5-27F2-4B78-A415-6375441203E4Q41438064-E4DFB044-B664-4373-949D-22BE53D2C01DQ42353667-FAAFCFC0-DC89-467D-B9BA-AB5AB4E2C7BCQ43542819-A54EDE45-C80E-4BDC-AA76-65DAC58F2954Q43795420-FC2A189D-CF2D-42B7-9CCF-9A98CFFBFDC6Q44455124-31E6DF0B-1A20-41D6-8546-5EC03F2A7221
P2860
Phase II study of short-course radiotherapy plus concomitant and adjuvant temozolomide in elderly patients with glioblastoma.
description
2011 nî lūn-bûn
@nan
2011 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Phase II study of short-course ...... ly patients with glioblastoma.
@ast
Phase II study of short-course ...... ly patients with glioblastoma.
@en
type
label
Phase II study of short-course ...... ly patients with glioblastoma.
@ast
Phase II study of short-course ...... ly patients with glioblastoma.
@en
prefLabel
Phase II study of short-course ...... ly patients with glioblastoma.
@ast
Phase II study of short-course ...... ly patients with glioblastoma.
@en
P2093
P1476
Phase II study of short-course ...... rly patients with glioblastoma
@en
P2093
Claudia Scaringi
Gaetano Lanzetta
Giuseppe Minniti
Maurizio Salvati
Paola Caporello
Riccardo Maurizi Enrici
Vitaliana De Sanctis
P356
10.1016/J.IJROBP.2011.06.1992
P407
P577
2011-11-11T00:00:00Z